In a patient with an elevated thyroid‑stimulating hormone (TSH) of 6.4 mIU/L, normal free thyroxine (free T4), and positive thyroid peroxidase (TPO) antibodies, should I also order a triiodothyronine (T3) measurement?

No, Do Not Order T3

In a patient with elevated TSH (6.4 mIU/L), normal free T4, and positive TPO antibodies—consistent with subclinical hypothyroidism—measuring T3 is not indicated and adds no diagnostic or management value. 1

Why T3 Measurement Is Not Helpful

The diagnosis of subclinical hypothyroidism is established by TSH and free T4 alone; T3 measurement does not contribute to this diagnosis. 1 Here's the reasoning:

• Subclinical hypothyroidism is defined biochemically as elevated TSH with normal free T4, which you already have. 1

• T3 levels remain normal in subclinical hypothyroidism and do not become abnormal until overt hypothyroidism develops (when free T4 drops). 2, 3

• T3 is not part of the diagnostic criteria for any form of primary hypothyroidism in current guidelines. 1, 2

• T3 measurement is primarily useful for hyperthyroidism, not hypothyroidism, as it helps detect T3-toxicosis when TSH is suppressed. 1, 4

What Your Current Results Tell You

Your patient has:

• Subclinical hypothyroidism (TSH 6.4 mIU/L with normal free T4) 1

• Autoimmune (Hashimoto's) thyroiditis as the underlying cause (positive TPO antibodies) 5

• Higher risk of progression to overt hypothyroidism at approximately 4.3% per year due to TPO positivity, compared to 2.6% per year in antibody-negative patients 5

Appropriate Next Steps

Instead of ordering T3, focus on these evidence-based actions:

• Confirm the diagnosis by repeating TSH and free T4 in 2–3 months, as transient TSH elevations can occur. 1, 2

• Do not re-check TPO antibodies—they remain elevated and provide no additional management guidance once positive. 5

• Monitor thyroid function every 6 months once subclinical hypothyroidism is confirmed, to detect progression to overt disease. 5, 2

• Consider treatment initiation if TSH rises above 10 mIU/L, if the patient is symptomatic, pregnant, planning pregnancy, or has cardiovascular risk factors. 2, 3

Common Pitfall to Avoid

Clinicians often reflexively order "complete thyroid panels" including T3, but this leads to unnecessary testing and potential confusion. 6 In hypothyroidism (whether subclinical or overt), T3 levels do not guide diagnosis or treatment decisions and can remain falsely reassuring even when patients are under-replaced or over-replaced on levothyroxine. 6